Core Viewpoint - 康龙化成 (03759) experienced a decline of over 7%, currently trading at 23.18 HKD, with a transaction volume of 27.84 million HKD [1] Group 1: Company Announcement - 康龙化成 announced a proposed placement of approximately 58.44 million new H-shares, representing about 3.19% of the company's enlarged total issued shares and about 16.57% of the total issued H-shares [1] - The placement price is set at 22.82 HKD per share, reflecting a discount of approximately 8.5% compared to the closing price on January 14 [1] Group 2: Use of Proceeds - The company expects to raise approximately 1.334 billion HKD in total proceeds, with a net amount of about 1.319 billion HKD from the placement [1] - Approximately 70% of the proceeds will be allocated to project construction, aimed at enhancing laboratory service facilities, drug process development, and production capacity [1] - About 10% of the proceeds will be used to repay bank loans and other borrowings to optimize the capital structure, while the remaining 20% will be allocated for working capital and other general purposes [1]
港股异动 | 康龙化成(03759)大跌超7% 拟折让8.5%配股净筹近13.2亿港元